KFSH&RC Strives to Pioneer in Maximizing Healthcare Spending Value
2024年5月11日 - 7:01PM
Dr. Majid Al Fayyadh, CEO of King Faisal Specialist Hospital and
Research Centre (KFSH&RC) joined the Gulf Creatives Conference
(GCC) at Harvard 2024. The event, GCC at Harvard, is organized by
The Diwan, an organization run by graduate students at Harvard
University. In his address, Dr. Al Fayyadh showcased the
KFSH&RC’s journey since its inception in Riyadh almost five
decades ago, highlighting how it has significantly reduced the need
for patients to travel abroad for medical care. KFSH&RC has
evolved into a premier provider of tertiary healthcare services and
today offers cutting-edge treatments for heart diseases, tumors,
organ transplantation, and genetic disorders.
Dr. Al Fayyadh discussed KFSH&RC's
transformation into an independent, non-profit foundation. This
move, he indicated, aligns with the organization's strategic vision
to become a global healthcare innovation leader, emphasizing
excellence, innovation, and investment in cutting-edge technology
to tackle global health challenges.
"The Saudi Leadership has outlined a clear
vision for KFSH&RC, mandated by a royal decree transitioning
the hospital into an independent Sui Generis, non-profit
foundation," stated His Excellency, Dr. Al Fayyadh.
He further highlighted that this transformation
seeks to elevate global healthcare standards through increased
independence and flexibility. This shift will allow KSFH&RC to
optimize existing services, pursue new opportunities, and direct
resources toward initiatives that promote human health and
well-being both within the Kingdom and internationally. Ultimately,
this move reinforces KFSH&RC's dedication to patient-centered
excellence.
Dr. Al Fayyadh pointed out that KFSH&RC
envisions itself as a leader in maximizing the value of healthcare
spending, adhering to evidence-based practices to ensure optimal
patient outcomes. It seeks to remain at the forefront of global
healthcare innovation, with initiatives designed to increase health
equity and access worldwide. To achieve this, KFSH&RC will
continue to invest in cutting-edge medical facilities, advanced
diagnostic equipment, and state-of-the-art treatment technologies.
Building on existing progress in areas like CAR T-cell therapy,
robotic surgeries, organ transplants, and personalized medicine,
the institution aims to achieve global competitiveness. This will
be further supported by fostering an exceptional workforce,
pursuing Nobel Prize-caliber breakthroughs, and strengthening
strategic international collaborations.
Dr. Al Fayyadh joined a panel discussion
focusing on the evolving landscape of the healthcare sector and the
positive outcomes of KFSH&RC’s ongoing transformation in
patient care. He also addressed current challenges and anticipated
future developments within the healthcare sector, emphasizing the
profound impact of the hospital's innovations on global healthcare
advancement. Additionally, Dr. Al Fayyadh highlighted the effective
role of the hospital's transformative initiatives in aligning with
the objectives of the Health Sector Transformation Program and
Saudi Vision 2030.
KFSH&RC is recognized as one of the leading
global institutions that provide specialized healthcare, drive
innovation, and serve as an advanced medical research and education
hub. It is dedicated to developing medical technologies and
elevating healthcare standards worldwide, forging partnerships with
leading local, regional, and international institutions to deliver
world-class services in clinical, research, and educational
domains.
For the second year running, KFSH&RC has
retained its status as the leading institution in the Kingdom and
ranks 20th globally among the top 250 academic medical centers
worldwide. It is also recognized as the most valuable healthcare
brand in the Kingdom and the Middle East in 2024, according to
Brand Finance, and has been ranked among the world's top 250
hospitals by Newsweek Magazine.
About King Faisal Specialist Hospital and Research
Centre:
King Faisal Specialist Hospital & Research
Centre stands among the global leaders in providing specialized
healthcare, driving innovation, and serving as an advanced medical
research and education hub. Through strategic partnerships with
prominent local, regional, and international institutions, the
hospital is dedicated to advancing medical technologies and
elevating healthcare standards worldwide.
The hospital has secured its position as the
leading brand in the healthcare sector across the Kingdom and the
Middle East, marking its second consecutive year as the most
valuable healthcare brand. It ranks 9th within the Kingdom and 28th
in the Middle East. The hospital distinguishes itself as the sole
hospital globally to break into the top 10 brands in its country,
as highlighted in two reports by “Brand Finance” on the 50 most
valuable brands in Saudi Arabia and the 150 most valuable brands in
the Middle East in 2024.
Due to the transformation programs and the
Kingdom’s Vision 2030, launched by His Royal Highness the Crown
Prince and Prime Minister - may God protect him - to enhance the
Kingdom’s leadership in the global healthcare sector, KFSH&RC
has emerged as a leading Academic Medical Centre in the Middle East
and Africa. It maintained its 20th rank globally for the second
consecutive year in 2024, according to "Brand Finance."
Additionally, it has been ranked among the top 250 hospitals
globally in 2024 by the American magazine "Newsweek."
For further information, please contact:
Mr. Essam AlZahrani, Acting Head of Media Affairs,
0555254429
Mr. Abdullah Alown, Media Coordination Officer, 0556294232
Photos accompanying this announcement are available
at:https://www.globenewswire.com/NewsRoom/AttachmentNg/d9d0ed27-fa87-49ac-b72b-ccf5b5843637https://www.globenewswire.com/NewsRoom/AttachmentNg/682fadee-20a5-4328-bf00-e036bc3350fd